Related references
Note: Only part of the references are listed.HDR interventional radiotherapy (brachytherapy) in the treatment of primary and recurrent head and neck malignancies
Francesco Bussu et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2019)
OnabotulinumtoxinA for adductor spasmodic dysphonia (ADSD): Functional results and the role of dosage
M. R. Marchese et al.
TOXICON (2018)
Botulinumtoxin therapy in Frey's syndrome: a retrospective study of 440 treatments in 100 patients
S. Jansen et al.
CLINICAL OTOLARYNGOLOGY (2017)
Botulinum toxin therapy: functional silencing of salivary disorders
A. Lovato et al.
ACTA OTORHINOLARYNGOLOGICA ITALICA (2017)
Clinical History, Prognostic Factors, and Management of Facial Nerve in Malignant Tumors of the Parotid Gland
Francesco Bussu et al.
CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY (2014)
The incidence of Frey syndrome following parotidectomy. Results of a survey and follow-up
A. Neumann et al.
HNO (2011)
Gustatory itching: an unusual complication following superficial parotidectomy
R. Ricks et al.
JOURNAL OF LARYNGOLOGY AND OTOLOGY (2010)
Repeated Botulinum Toxin Type A Injections to Treat Patients With Frey Syndrome
Remco de Bree et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2009)
Incidence of Frey's syndrome
Jan Rustemeyer et al.
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2008)
Botulinum toxin A in the treatment of patients with Frey syndrome
AJF Beerens et al.
BRITISH JOURNAL OF SURGERY (2002)
Botulinum toxin: Basic science and clinical uses in otolaryngology
A Blitzer et al.
LARYNGOSCOPE (2001)
Share Paper
